AIDOC is a Healthtech company based in Tel Aviv, Israel. It has raised $500M in total funding. Latest round: Series E.
AIDOC funding overview
AIDOC is a Healthtech company based in Tel Aviv, Israel. AIDOC has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2026. The round record for AIDOC runs through 2026; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
AIDOC at a glance
Total raised
$500M
Latest round
Series E
Latest round date
April 2026
Industry
Healthtech
Headquarters
Tel Aviv, Israel
Notable investors
Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital, CDIB Capital, Square Peg
Frequently asked about AIDOC funding
How much has AIDOC raised?
AIDOC has raised $500M in total disclosed funding across the rounds on record.
Who has invested in AIDOC?
Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital are named among the investors backing AIDOC.
What was the latest AIDOC funding round?
The most recent disclosed round is a Series E, announced in April 2026.
Where is AIDOC based?
AIDOC is based in Tel Aviv, Israel.
What sector does AIDOC operate in?
AIDOC is tracked under Healthtech from Tel Aviv, Israel, with $500M in disclosed funding.
When did AIDOC last raise?
The last disclosed AIDOC round closed in April 2026 at Series E.
AIDOC totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in Tel Aviv below to benchmark round size and investor mix.
